Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

451.48
Delayed Data
As of Mar 31
 -8.30 / -1.81%
Today’s Change
269.50
Today|||52-Week Range
495.50
+10.05%
Year-to-Date

Today’s Trading

Previous close459.78
Today’s open456.23
Day’s range450.02 - 464.52
Volume885,141
Average volume (3 months)892,525
Market cap$47.2B
Dividend yield--
Data as of 4:14pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+5.20%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio147.1
Price/Sales14.64
Price/Book18.52

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-3.36-3.12%
QQuintiles Transnatio...-1.03-1.51%
ISISIsis Pharmaceuticals...-1.14-1.76%
ICLRICON PLC-0.40-0.56%
Data as of 4:03pm ET, 03/31/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$2.68
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account